History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Fred's Team Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment

Also Known As: Blenoxane®


Class: Antitumor antibiotic


Late Effect (1st of 1)

Pulmonary fibrosis (loss of elasticity in the lungs causing shortness of breath)

Your risk is greater if:

  • You were young when you were treated.
  • You received a dose greater than 400 U/m².
  • It was combined with:
    - Other therapy toxic to the lungs (e.g., methotrexate, cyclophosphamide, doxorubicin)
    - Radiation therapy to the chest, spine, or total body.
  • ­You have kidney problems.
  • You have high concentrations of oxygen during anesthesia.
  • ­You smoke.

Recommended Evaluation

  • ­Physical exam yearly
  • Pulmonary function tests at the end of treatment and then every 2-3 years and before anesthesia (Make sure you discuss your medical history with the anesthesiologist if you need to have surgery.)
  • Chest x-ray at the end of treatment and then every 2-3 years
  • Chest x-ray before anesthesia

Management

  • Do not smoke.
  • Do aerobic exercise regularly to improve stamina and endurance.
  • ­Do not scuba dive.
  • ­Be sure to discuss your medical history with your doctor and make sure he/she is aware of the risk of worsening fibrosis with high oxygen during anesthesia.
  • Have flu vaccine shots yearly.
Return to Chemotherapy Main Page
PrintEmail This Page